fbpx Skip to main content



JCI Home  

Our mission is to improve and streamline the experience of patients and study investigators by reducing burdens and overall costs to expedite drug development and delivery.


Through pilot programs and open collaborations within Janssen – and across industry and institutions – JCI seeks to drive and catalyze a global transformation of clinical research to a more data-intensive, yet patient-centric, model. Areas we are actively exploring include but not limited to:


the universe of real-world data (RWD)*, drawn from existing sources or newly captured from patients’ lived experience, to drive accelerated discovery and development.


the technologies and procedures for clinical research, so sites work more efficiently, and patient participation feels less like effort and more like care.


the very nature of clinical research through study decentralization, patient data sharing, and study designs merging key features of real-world evidence (RWE)** and prospective trials.



*Real-World Data (RWD) are data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources.1
**Real-World Evidence (RWE) is the clinical evidence about the usage and potential benefits or risks of a medical product derived from analysis of RWD.1


1 U.S. Food and Drug Administration. Framework for FDA’s Real-World Evidenced Based Program. Available at: https://www.fda.gov/media/120060/download